Genetic variability and the risk of myocardial infarction in Poles under 45 years of age.

Arch Med Sci 2010 Apr;6(2):160-7

Department of Medical Biotechnology, Medical University of Lodz, Poland.

Introduction: Myocardial infarction is caused by the obstruction of an artery in places of atherosclerosis plaque rupture. Endothelial cells during their activation express chemoattractant and adhesion molecules whereas infiltrating inflammatory cells produce enzymes, predisposing a lesion to rupture.

Material And Methods: We investigated the correlation between polymorphisms in the human genes E-selectin (Ser128Arg), ICAM1 (K469E), OLR1 (K167N), MMP1 (1G/2G) and MMP3 (-1612 5A/6A) and the risk of MI in young Poles under 45 years. There was no significant difference in the frequency of single nucleotide polymorphism (SNP) of the studied genes E-selectin (Ser128Arg), ICAM1 (K469E), OLR1 (K167N) and MMP3 (-1612 5A/6A) between patients with MI and controls.

Results: The analysis of the association of the 1G2G polymorphism with the risk of myocardial infarction indicated an odds ratio (OR) of 5.68 (95% confidence interval [95% CI] 2.60 to 12.36). Other factors associated with myocardial infarction were: smoking (OR 4.12; 95% CI 1.63-10.44), male sex (OR 16.02; 95% CI 5.90-43.46), hypercholesterolaemia (OR 2.74; 95% CI 1.29-5.83) and arterial hypertension (OR 4.56; 95% CI 1.66-14.47).

Conclusions: We found that only MMP1 1G/2G polymorphism is associated with myocardial infarction in the Polish population of individuals younger than 45 years. Clinical factors seemed to play a greater role in the analysed group.

Download full-text PDF

Source
http://dx.doi.org/10.5114/aoms.2010.13887DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281334PMC
April 2010

Publication Analysis

Top Keywords

myocardial infarction
20
associated myocardial
8
poles years
8
genes e-selectin
8
e-selectin ser128arg
8
icam1 k469e
8
olr1 k167n
8
ser128arg icam1
8
k469e olr1
8
mmp1 1g/2g
8
risk myocardial
8
mmp3 -1612
8
-1612 5a/6a
8
95%
5
myocardial
5
infarction
5
568 95%
4
95% 590-4346
4
k167n mmp1
4
1g/2g mmp3
4

Similar Publications

Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction.

Thromb Haemost 2003 Jul;90(1):132-9

Department of Internal Medicine, College of Medicine, National Cheng-Kung University, Tainan, Taiwan.

The objective of this study was to elucidate the association between the polymorphism of stromelysin-1, also called matrix metalloproteinases-3 (MMP-3), and smoking in the pathogenesis of young acute myocardial infarction (MI). Plaque rupture is well established as a critical factor in the pathogenesis of acute MI. MMP-3 can degrade extracellular matrix and are identified extensively in human coronary atheroslcerotic plaques, and may contribute to the weakening of the cap and subsequent rupture. Read More

View Article and Full-Text PDF
July 2003

Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis.

Carcinogenesis 2009 May 25;30(5):793-8. Epub 2009 Mar 25.

Medical Oncology and Hematology, Biostatistics, Princess Margaret Hospital and Department of Medicine, Dalla Lama School of Public Health and University of Toronto, Ontario, Canada.

The matrix metalloproteinase (MMP) family degrade extracellular matrix and mediate pathways including apoptosis, angiogenesis and immunity. We studied the association between four MMP polymorphisms within three MMP genes and esophageal adenocarcinoma (EA) risk and prognosis. A total of 313 EA cases and 455 age and gender frequency-matched controls were genotyped for MMP1 1G/2G, MMP3 6A/5A, MMP12 -82A/G and MMP12 1082A/G. Read More

View Article and Full-Text PDF
May 2009

Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.

Mutagenesis 2010 Jan 20;25(1):41-8. Epub 2009 Oct 20.

State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, People's Republic of China.

Matrix metalloproteinase (MMP) 1 and MMP3 are enzymes that degrade the extracellular matrix and have been implicated to play an important role in cancer development. Many studies have been carried out on the association between polymorphisms of MMP1 -1607 1G>2G and MMP3 -1171 5A>6A and cancer risk. However, results from these studies remain inconclusive. Read More

View Article and Full-Text PDF
January 2010

Association of Maternal and Fetal Single-Nucleotide Polymorphisms in Metalloproteinase (, , , and ) Genes with Preeclampsia.

Dis Markers 2018 18;2018:1371425. Epub 2018 Feb 18.

Department of Medical Biotechnology, Medical University of Lodz, Łódź, Poland.

Background: Metalloproteinases (MMPs) play a pivotal role during the process of trophoblast invasion and placentation. The appearance of five functional single-nucleotide polymorphisms (SNP) in the genes of the metalloproteinases most commonly implicated in the implantation process may influence the development of preeclampsia.

Methods: Blood samples were collected from 86 mothers and 86 children after preeclampsia and 85 mothers and 85 children with uncomplicated pregnancies. Read More

View Article and Full-Text PDF
September 2018